Yijia Group (YJGJ) plans reverse split, name change and higher share authorization
Rhea-AI Filing Summary
Yijia Group Corp. plans several major corporate changes. The company intends to change its name to VitaNova Life Sciences Corporation, with a new ticker symbol to follow on OTC Markets; until then, its common stock will continue trading under YJGJ with the current CUSIP.
The board and a majority of common shareholders have approved a reverse stock split in a ratio range of 1-for-2 to 1-for-3, meaning each shareholder would receive one new share for every two or three existing shares once the final ratio is set. They also approved an increase in authorized capital to 85,000,000 shares, consisting of 75,000,000 common and 10,000,000 preferred shares, and the creation of blank check preferred stock that the board can designate into series with different rights over time. These changes will be implemented by filing a Certificate of Amendment with the Nevada Secretary of State after the reverse split ratio is finalized.
Positive
- None.
Negative
- None.
Insights
Yijia plans a reverse split, name change, and major boost in authorized capital.
Yijia Group Corp. is restructuring its corporate profile by rebranding as VitaNova Life Sciences Corporation and planning a new trading symbol on OTC Markets. Such rebranding can signal a shift in strategic focus, although the excerpt does not describe any specific business change beyond the new name.
The board and a majority of common shareholders have approved a reverse stock split in the 1-for-2 to 1-for-3 range. Reverse splits reduce the number of shares outstanding and typically raise the per-share trading price mechanically, without changing a holder’s overall economic interest at the moment of the split.
The company is also increasing authorized capital to 85,000,000 shares, with 75,000,000 common and 10,000,000 preferred shares, and establishing blank check preferred stock the board can designate later. This provides flexibility to issue new equity or preferred securities in the future, which could be used for financing, acquisitions, or other corporate purposes depending on subsequent decisions and market conditions.
8-K Event Classification
AI-generated analysis. How Rhea-AI works. Not financial advice.